Skip to search
Skip to main content
Back to Search
Start Over
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in PracticeSubstudy
Authors :
Louis, Renaud Harrison, Tim W. Chanez, Pascal Menzella, Francesco Philteos, George Cosio, Borja G. Lugogo, Njira L. de Luiz, Gustavo Burden, Annie Adlington, Timothy Keeling, Nanna Kwiatek, Justin Garcia Gil, Esther Pohl, Wolfgang Doberer, Daniel Martinot, Jean Benoit Deschampheleire, Maud Himpe, Ulrike Chapman, Kenneth Cheema, Amarjit Dorscheid, Delbert Ramsey, Clare Rolf, Jeffrey Walker, Brandie Olivenstein, Ronald Poirier, Claude Larivee, Pierre Bjerrum, Anne Sofie Titlestad, Ingrid Hilberg, Ole Kilpeläinen, Maritta Bonniaud, Philippe Taillé, Camille Tiotiu, Iuliana-Angelica Girodet, Pierre-Olivier Blanc, François-Xavier Pradelli, Johana Didier, Alain Nocent Ejnaini, Cecilia Deslee, Gaetan Pison, Christophe Douadi, Youcef Mahay, Guillaume Devouassoux, Gilles Melloni, Boris Roux, Pauline-Marie Bourdin, Arnaud Fry, Stephanie Schaum, Thomas Schulz, Christian Skowasch, Dirk Taube, Christian Welte, Tobias Gleiber, Wolfgang Brehler, Randolf Schreiber, Jens Schuette, Wolfgang Kronsbein, Juliane Bonnet, Reiner Beck, Ekkehard Lacedonia, Donato Senna, Gianenrico Caruso, Cristiano Crimi, Nunzio Blasi, Francesco Santus, Pierachille Canonica, Giorgio Walter Guarnieri, Gabriella Pelaia, Girolamo Milanese, Manlio Micheletto, Claudio Corsico, Angelo Guido Scichilone, Nicola Spadaro, Giuseppe Langeveld, Bas Holters, Jurgen Willem van den Berg, Jan Smit, Arthur Conemans, Lennart van Veen, Helena Staaks, Gerald Lehmann, Sverre Echave-Sustaeta, Jose Maria Ribas, Christian Domingo de Luiz Martinez, Gustavo Gonzalez Perez, Ruperto Garcia Rivero, Juan Luis Gall, Xavier Muñoz Soto Campos, Jose Gregorio Mozo, Paloma Campo Pan, Carmen Vidal Fernandez, Ana Gomez-Bastero Tellez, Sergio Campos Rivera, Carlos Martinez Bobolea, Irina Diana Guerrero, Raquel Morillo Garcia, Ismael Ali Rodriguez Hermosa, Juan Luis Stenfors, Nikolai Tunsäter, Alf Curiac, Dan von Garnier, Christophe Leuppi, Joerg Schmid-Grendelmeier, Peter Nasser, Shuaib Chaudhuri, Rekha Nordstrom, Monica Saralaya, Dinesh Pfeffer, Paul Mansur, Adel Short, Philip Wenzel, Sally Cherry, William Brett Zafra, Heidi Gonzalez, Erika Soong, Weily Davis, Benjamin Kao, Neil Hussain, Iftikhar Maselli Caceres, Diego Jose Harris, James Calhoun, William Rodicio, Ileana Kaufman, David Moss, Mark Sztejman, Eric DeLeon, Samuel Sumino, Kaharu Kashyap, Ravindra Leflein, Jeffrey Hajal, Rizan Fakih, Faisal Hill, David Lin, Robert Jarratt, Mikell Subramaniam, Vijay Sussman, Robert Mumneh, Nayla Reibman, Joan Darveaux, Jared Tan, Ricardo Tanus, Tonny Sikand, Vinay Marshall, Gailen Mehta, Hemalini Cole, Jeremy Goodman, Brad Goss, Deborah Bardelas, Jose Milstone, Aaron Mehta, Vinay Clore, Lee Millard, Mark Palumbo, Michael Puppala, Dileep Leong, Mila Prenner, Bruce Robinette, Emory Heidarian Raissy, Hengameh Fost, David Pleskow, Warren Marcus, Michael Ilowite, Jonathan Moore, Wendy Steven, Gary De la Cruz, Luis Chupp, Geoffrey Berger, William Randolph, Christopher Holguin, Fernando Kureishy, Shahrukh Campbell, Edward Peche, Rudi Pini, Laura Papi, Alberto Beghé, Bianca Peveri, Silvia Henriquez Santa, Aythamy Ramos Gonzalez, Jacinto Vinge, Ines St. John, Roy
Source :
The Journal of Allergy and Clinical Immunology: In Practice; June 2023, Vol. 11 Issue: 6 p1759-1770.e7
Publication Year :
2023
Abstract
The phase IIIb, randomized, parallel-group, placebo-controlled ANDHI double-blind (DB) study extended understanding of the efficacy of benralizumab for patients with severe eosinophilic asthma. Patients from ANDHI DB could join the 56-week ANDHI in Practice(IP) single-arm, open-label extension substudy.
Details
Language :
English
ISSN :
22132198
Volume :
11
Issue :
6
Database :
Supplemental Index
Journal :
The Journal of Allergy and Clinical Immunology: In Practice
Publication Type :
Periodical
Accession number :
ejs62575106
Full Text :
https://doi.org/10.1016/j.jaip.2023.03.009